AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 152 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,623,227 | -15.1% | 853,262 | 0.0% | 9.88% | -18.1% |
| Q2 2023 | $18,404,861 | -32.6% | 853,262 | -8.3% | 12.06% | +19.7% |
| Q1 2023 | $27,296,088 | -10.0% | 930,337 | +13.3% | 10.08% | +81.8% |
| Q4 2022 | $30,344,079 | +53.9% | 821,220 | +17.2% | 5.54% | +137.7% |
| Q3 2022 | $19,723,000 | +46.2% | 700,635 | 0.0% | 2.33% | +67.9% |
| Q2 2022 | $13,494,000 | +70.1% | 700,635 | +13.5% | 1.39% | +94.1% |
| Q1 2022 | $7,931,000 | – | 617,220 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
| Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
| GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
| Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
| Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
| Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
| EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
| SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |